XML 18 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Balance Sheets (USD $)
Oct. 31, 2014
Jan. 31, 2014
Current Assets:    
Cash $ 31,534us-gaap_CashAndCashEquivalentsAtCarryingValue $ 8,986us-gaap_CashAndCashEquivalentsAtCarryingValue
Total Assets 31,534us-gaap_Assets 8,986us-gaap_Assets
Current Liabilities:    
Accounts payable and accrued expenses 43,000us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 45,999us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Total current liabilities 43,000us-gaap_LiabilitiesCurrent 45,999us-gaap_LiabilitiesCurrent
Due to Shareholder 306,045us-gaap_DueToOfficersOrStockholdersNoncurrent 221,895us-gaap_DueToOfficersOrStockholdersNoncurrent
Total liabilities 349,045us-gaap_Liabilities 267,894us-gaap_Liabilities
Shareholders' Deficiency    
Preferred stock, 50,000,000 shares authorized, $0.001 par value; no shares issued or outstanding 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, 200,000,000 shares authorized; $0.001 par value; 1,233,853 shares issued and outstanding 1,233us-gaap_CommonStockValue 1,233us-gaap_CommonStockValue
Additional paid-in capital 81,323us-gaap_AdditionalPaidInCapital 81,323us-gaap_AdditionalPaidInCapital
Accumulated deficit (213,038)us-gaap_RetainedEarningsAccumulatedDeficit (213,038)us-gaap_RetainedEarningsAccumulatedDeficit
Deficit accumulated during the development stage (187,029)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage (128,426)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
Total shareholders' deficiency (317,511)us-gaap_StockholdersEquity (258,908)us-gaap_StockholdersEquity
Total liabilities and shareholders' deficiency $ 31,534us-gaap_LiabilitiesAndStockholdersEquity $ 8,986us-gaap_LiabilitiesAndStockholdersEquity